Skip to content

Praxsyn Corp

company.status.inactive

CIK 1346973fmd_1D0CFNSF50TRGJM0T95F1TPND7Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2009 to Sep 30, 2015, 23 periods

Income Statement · Annual · Millions · USD
Line itemFY2009FY2010FY2011FY2012FY2013FY2014
Total revenues1126767
Cost of revenue122114
Gross profit(0)(0)(0)5663
Selling, general and administrative14416337
Total operating expenses–––16337
Operating income(1)(4)(4)(12)326
Interest expense–01–232
Other non-operating income (expense)0(0)(3)(1)(2)(39)
Income before taxes(1)(4)(8)(18)1(13)
Income tax expense––0(2)1(0)
Net income from continuing operations––(8)(1)(5)(12)
Net income(1)(4)(8)(16)0(12)
Net income to common shareholders––––0(12)
Praxsyn Corp financial statements · FinancialMD